Irrus Investments

Irrus Investments is a leading Irish business angel syndicate based in Limerick that explicitly focuses on backing indigenous life science and high-tech companies. Operating as a private angel network rather than a fund, Irrus pools experienced Irish operators and executives who write early checks into medical devices, biotech, and health IT companies, often as the first institutional-quality money in. The group plays a notable role in the Irish regional ecosystem, particularly for companies emerging from University of Limerick and surrounding research bases.

Irrus deploys Seed-stage capital with checks under $250k, typically syndicated alongside Enterprise Ireland matched funding, HBAN syndicates, and other Irish angel groups. Geographic focus is firmly Ireland, with most activity in the Mid-West and broader Munster regions, though Dublin-based deals are considered when member ties exist.

Founders should engage through Irrus’s pitch screening process and arrive with a credible Enterprise Ireland co-funding plan, since most rounds are constructed around that match. Expect operator-led diligence rather than analyst-style memos, and prepare for follow-on conversations across the Irish angel ecosystem. A regional anchor and clear commercialization milestones are essential.